1.Blood glucose level after febrile convulsion.
Mohamed Amin GHOBADIFAR ; Naser HONAR ; Parisa JOOYA ; Fatemeh HASSANI
Korean Journal of Pediatrics 2016;59(3):153-154
No abstract available.
Blood Glucose*
;
Seizures, Febrile*
2.Blood glucose level after febrile convulsion.
Mohamed Amin GHOBADIFAR ; Naser HONAR ; Parisa JOOYA ; Fatemeh HASSANI
Korean Journal of Pediatrics 2016;59(3):153-154
No abstract available.
Blood Glucose*
;
Seizures, Febrile*
3.Diagnostic Value of Immunoglobulin G Anti-Deamidated Gliadin Peptide Antibody for Diagnosis of Pediatric Celiac Disease: A Study from Shiraz, Iran
Mohammad Hossein ANBARDAR ; Fatemeh Golbon HAGHIGHI ; Naser HONAR ; Mozhgan ZAHMATKESHAN
Pediatric Gastroenterology, Hepatology & Nutrition 2022;25(4):312-320
Purpose:
Screening serologic tests are important tools for the diagnosis of celiac disease (CD). Immunoglobulin (Ig)G anti-deamidated gliadin peptide (anti-DGP) is a relatively new autoantibody thought to have good diagnostic accuracy, comparable to that of anti-tissue transglutaminase (anti-tTG) antibody.
Methods:
Pediatric patients (n=86) with a clinical suspicion of CD were included. Duodenal biopsy, anti-tTG, and IgG anti-DGP antibody tests were performed. The patients were divided into CD and control groups based on the pathological evaluation of duodenal biopsies. The diagnostic accuracy of serological tests was determined.
Results:
IgA anti-tTG and IgG anti-DGP antibodies were positive in 86.3% and 95.4% of patients, respectively. The sensitivity, specificity, and diagnostic accuracy of the IgA anti-tTG test were 86.3%, 50.0%, and 68.6%, respectively, and those of the IgG anti-DGP test were 95.4%, 85.7%, and 90.7%, respectively. The area under the receiver operating characteristic (ROC) curve was 0.84 (95% confidence interval [CI], 0.74–0.91) for IgA anti-tTG test and 0.93 (95% CI, 0.86–0.97) for IgG anti-DGP test. The comparison of IgA anti-tTG and IgG anti-DGP ROC curves showed a higher sensitivity and specificity of the IgG anti-DGP test.
Conclusion
IgG anti-DGP is a reliable serological test for CD diagnosis in children. High tTG and DGP titers in the serum are suggestive of severe duodenal atrophy. The combined use of IgA anti-tTG and IgG anti-DGP tests for the initial screening of CD can improve diagnostic sensitivity.
4.Association between TransfusionRelated Iron Overload and Liver Fibrosis in Survivors of Pediatric Leukemia: A Cross-Sectional Study
Mahsa SOBHANI ; Naser HONAR ; Mohammadreza FATTAHI ; Sezaneh HAGHPANAH ; Nader SHAKIBAZAD ; Mohammadreza BORDBAR
Pediatric Gastroenterology, Hepatology & Nutrition 2024;27(4):215-223
Purpose:
Patients who receive frequent blood transfusions are at an elevated risk of developing hepatic fibrosis due to iron overload in the liver. In this study, we evaluated the effectiveness of transient elastography (TE) (FibroScan® ) for assessing liver fibrosis in patients with pediatric cancer.
Methods:
We enrolled 106 consecutive cases of acute leukemia in individuals under 21 years of age. The participants were followed for 2 years. Based on their serum ferritin (SF) levels, the patients were divided into two groups: group 1 (SF≥300 ng/mL) and group 2 (SF<300 ng/mL). A liver FibroScan® was performed, and a p-value of less than 0.05 was considered statistically significant.
Results:
Among the various parameters in the liver function test (LFT), alkaline phosphatase was significantly higher in a subgroup of patients aged 5–8 years in group 2 compared to those in group 1. The indices of liver fibrosis determined by TE, including the FibroScan score, controlled attenuation parameter score, steatosis percentage, and meta-analysis of histological data in viral hepatitis score, as well as indirect serum markers of liver fibrosis such as the aminotransferase (AST)/alanine aminotransferase (ALT) ratio, Fibrosis 4 score, and AST to platelet ratio index, did not differ significantly between the two groups. The association between the TE results and LFT parameters was only significant for ALT.
Conclusion
Transfusion-associated iron overload does not have a significant correlation with severe liver fibrosis. FibroScan® is not a sensitive tool for detecting early stages of fibrosis in survivors of pediatric leukemia.